High-Throughput Screen for Novel Antimicrobials using a Whole Animal Infection Model

被引:159
作者
Moy, Terence I. [1 ,2 ,3 ]
Conery, Annie L. [2 ,3 ]
Larkins-Ford, Jonah [2 ,3 ]
Wu, Gang [2 ,3 ]
Mazitschek, Ralph [4 ]
Casadei, Gabriele [5 ]
Lewis, Kim [5 ]
Carpenter, Anne E. [6 ]
Ausubel, Frederick M. [1 ,2 ,3 ]
机构
[1] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA
[5] Northeastern Univ, Dept Biol, Boston, MA 02115 USA
[6] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
关键词
ANTIBACTERIAL DRUG DISCOVERY; CAENORHABDITIS-ELEGANS; C-ELEGANS; INHIBITORS; BACTERIAL; ASSAY;
D O I
10.1021/cb900084v
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The nematode Coenorhabditis elegons is a unique whole animal model system for identifying small molecules with in vivo anti-infective properties. C elegons can be infected with a broad range of human pathogens, including Enterococcus faecalis, an important human nosocomial pathogen. Here, we describe an automated, high-throughput screen of 37,200 compounds and natural product extracts for those that enhance survival of C elegans infected with E faecalis. Using a robot to dispense live, infected animals into 384-well plates and automated microscopy and image analysis, we identified 28 compounds and extracts not previously reported to have antimicrobial properties, including six structural classes that cure infected C elegons animals but do not affect the growth of the pathogen in vitro, thus acting by a mechanism of action distinct from antibiotics currently in clinical use.
引用
收藏
页码:527 / 533
页数:7
相关论文
共 23 条
[1]  
BEANAN MJ, 1992, DEVELOPMENT, V116, P755
[2]   Antibacterial drug discovery: is small pharma the solution? [J].
Boggs, AF ;
Miller, GH .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 :32-36
[4]   CellProfiler: image analysis software for identifying and quantifying cell phenotypes [J].
Carpenter, Anne E. ;
Jones, Thouis Ray ;
Lamprecht, Michael R. ;
Clarke, Colin ;
Kang, In Han ;
Friman, Ola ;
Guertin, David A. ;
Chang, Joo Han ;
Lindquist, Robert A. ;
Moffat, Jason ;
Golland, Polina ;
Sabatini, David M. .
GENOME BIOLOGY, 2006, 7 (10)
[5]   The biology and future prospects of antivirulence therapies [J].
Cegelski, Lynette ;
Marshall, Garland R. ;
Eldridge, Gary R. ;
Hultgren, Scott J. .
NATURE REVIEWS MICROBIOLOGY, 2008, 6 (01) :17-27
[6]   An automated high-throughput assay for survival of the nematode Caenorhabditis elegans [J].
Gill, MS ;
Olsen, A ;
Sampayo, JN ;
Lithgow, GJ .
FREE RADICAL BIOLOGY AND MEDICINE, 2003, 35 (06) :558-565
[7]   Discovery of O-GlcNAc transferase inhibitors [J].
Gross, BJ ;
Kraybill, BC ;
Walker, S .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (42) :14588-14589
[8]   High-throughput screens for small-molecule inhibitors of Pseudomonas aeruginosa biofilm development [J].
Junker, Lauren M. ;
Clardy, Jon .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (10) :3582-3590
[9]   A small-molecule screen in C-elegans yields a new calcium channel antagonist [J].
Kwok, TCY ;
Ricker, N ;
Fraser, R ;
Chan, AW ;
Burns, A ;
Stanley, EF ;
McCourt, P ;
Cutler, SR ;
Roy, PJ .
NATURE, 2006, 441 (7089) :91-95
[10]   Targeting virulence for antibacterial chemotherapy: Identifying and characterising virulence factors for lead discovery [J].
Marra A. .
Drugs in R & D, 2006, 7 (1) :1-16